Book a Consultation
A prostate cancer diagnosis often arrives with a difficult mix of urgency and uncertainty. Some prostate cancers need treatment soon. Others can be watched closely first.
The hard part is knowing which situation is yours. Our team in Brooksville sees patients from Spring Hill, Weeki Wachee, and across Hernando County. We help you read what your reports actually mean.
Treatment for prostate cancer is not planned by stage alone. Your team also weighs prostate-specific antigen (PSA), Grade Group or Gleason score, and tumor extent. Age, health, and your priorities matter too.
A low PSA with a higher Grade Group can mean something different than a higher PSA with low-grade cells. Our prostate cancer and its treatment guide walks through these inputs in more depth.
Localized prostate cancer is still inside the prostate. Some low-risk cases are watched with active surveillance. Others use radiation or surgery coordinated outside ACTC.
Regional disease may involve nearby tissue or pelvic lymph nodes. Plans often combine radiation with hormone therapy for a defined period.
Metastatic prostate cancer has reached distant sites, often bone. It is usually treatable but not curable. Medical oncology becomes central, and radiation may still help control specific symptoms.
Before treatment starts, your team needs to know where the cancer is. The right answers come from layered testing, not a single number.
Your PSA trend, biopsy report, and imaging each answer a different question. Some patients also need extra scans to look closer.
Common added scans include MRI (magnetic resonance imaging) and CT (computed tomography, a detailed X-ray). A bone scan or PET (positron emission tomography, which highlights active tissue) may also help.
The differences between CT and PET scans are worth a quick read before your visit. ACTC keeps a full in-house laboratory, detailed X-ray imaging, and mobile PET access in one Brooksville building.
At the planning visit, we want clear answers to a short list
•Surveillance or treatment now: Is your cancer low-risk enough to watch?
•Local versus systemic: Would radiation, surgery, medicine, or a mix fit best?
•Hormone therapy fit: Would adding hormone therapy strengthen the plan?
•Schedule shape: Is a shorter radiation course safe for you?
•Side-effect priorities: Which side effects matter most when comparing options?
The right plan depends on whether your cancer is low-risk, intermediate-risk, high-risk, recurrent, or metastatic. We explain why each option is on the table.
For low-risk localized cancer, active surveillance is often a strong choice. For favorable intermediate-risk disease, surveillance, radiation, or surgery may all be reasonable.
Unfavorable intermediate-risk and high-risk localized cancers often involve radiation plus hormone therapy. Surgery is also an option for selected patients. Some men need radiation after surgery if pathology shows higher recurrence risk.
Stage IVA disease may include radiation to the prostate and pelvis with hormone therapy. Stage IVB disease usually leans on hormone therapy as the backbone. Some plans add chemotherapy or immunotherapy when appropriate.
Active surveillance is not the same as ignoring cancer. It is a structured monitoring plan for low-risk cancers when treatment side effects may outweigh the benefit. A surveillance plan includes scheduled PSA testing, exams, repeat imaging, and a follow-up biopsy. If signs of progression appear, the plan shifts to active treatment. Your oncology team coordinates the schedule.
Radiation oncology uses focused energy to treat cancer cells while sparing nearby tissue. Prostate plans may use intensity-modulated radiation therapy (IMRT) or image-guided radiation therapy (IGRT). Other plans use stereotactic body radiation therapy (SBRT).
Our radiation oncology team uses Varian VitalBeam technology and detailed X-ray planning to shape the radiation field around your prostate. The goal is a planned dose to the cancer with reduced exposure to the bladder and rectum.
SBRT delivers higher-dose treatments over fewer visits for selected patients. Some prostate SBRT courses run five or fewer outpatient sessions. Whether SBRT fits depends on prostate size, urinary symptoms, and anatomy.
Hormone therapy lowers or blocks testosterone signals that can fuel prostate cancer growth. It is often paired with radiation for intermediate-risk or high-risk disease. Side effects can include hot flashes, fatigue, sexual changes, and bone thinning.
If hormone therapy is part of your plan, steps to prevent osteoporosis after cancer treatment become more important. Your team will review bone health early.
Radical prostatectomy and other prostate surgeries are performed by a urologic surgeon at a hospital, not at ACTC. The same is true for bilateral orchiectomy when that approach is chosen.
Some internal-radiation approaches such as brachytherapy may be considered in certain risk groups. When that path fits, the placement is usually arranged at a specialty center. Your team can walk through what each option would mean.
Some patients have tumor or genetic testing to clarify risk or guide targeted therapy decisions. When relevant, your team can arrange the appropriate testing through a certified lab.
Side effects depend on which treatments you receive and in what order. Radiation can cause urinary frequency, urgency, and bowel changes. The bladder and rectum sit close to the treatment area.
Hormone therapy can affect energy, mood, sexual function, and bone density. Systemic medicines each have different patterns and monitoring schedules.
Most prostate cancer treatment side effects can be managed with a same-day call to your team. A few warning signs need a faster response.
Call 911 first for severe chest pain, sudden trouble breathing, slurred speech, or fainting. Heavy bleeding that does not stop, sudden severe headache, or one-sided weakness also call for 911.
Call our team the same day for fever with chills, a sudden inability to urinate, severe pelvic or back pain, or new leg weakness. Persistent blood in urine should also prompt a same-day call.
ACTC is a single 21,000-square-foot center at 15211 Cortez Boulevard in Brooksville, just east of the Suncoast Parkway. We see patients from Brooksville, Spring Hill, Weeki Wachee, Ridge Manor, and surrounding communities.
Radiation oncology and medical oncology sit under one roof. The building also holds an in-house laboratory, detailed X-ray imaging, mobile PET (positron emission tomography) access, an infusion room, and a treatment vault.
Financial counselors can help you understand insurance coverage and out-of-pocket costs. The team also treats related conditions such as penile cancer and bladder cancer.
At ACTC, cancer care is personal. Our Florida-based specialists design evidence-based treatment plans tailored to each patient’s needs, with attention to both medical and emotional well-being. You’ll have a team by your side that treats you like family—because that’s how we define care.
You can consult with any of the following providers at ACTC:
A prostate cancer diagnosis brings a lot of uncertainty, and you do not have to sort through it alone. Our team will walk through your reports and explain your options. Call us at 352-345-4565 or request an appointment to start the conversation.
Schedule a consultation by calling
352-345-4565
No, not always. Some low-risk prostate cancers can be safely watched on an active surveillance schedule. Whether that fits depends on PSA, Grade Group, biopsy findings, imaging, and your overall health.
It varies. A Gleason 7 is in the middle range, not the slowest-growing and not the most aggressive. Your team will look at the full picture, including the breakdown on your report and your PSA, before recommending how quickly to act.
It depends. Hormone therapy is often considered with radiation for intermediate-risk or high-risk localized cancer, and it is a backbone for many advanced cases. It is not needed for every patient.
Yes, sometimes. Recurrence is detected by a rising PSA, new symptoms, or new imaging findings, and the next step depends on what treatment you had. Options can include hormone therapy, more radiation, or systemic medicines.
Sometimes. Radiation may be recommended after surgery when pathology or PSA results suggest higher risk that cancer cells remain. Your team will explain whether the goal is adjuvant treatment, salvage treatment, or close monitoring.
Bring your PSA history, biopsy results, imaging reports on disc or by portal, a current medication list, and insurance information. A list of your questions helps us use the visit well.
Schedule a consultation by calling
352-345-4565
Subscribe to our newsletter
Social Links
15211 Cortez Boulevard, Brooksville, Florida 34613